Glenview Trust Co boosted its holdings in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 2.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 100,253 shares of the semiconductor company’s stock after purchasing an additional 1,993 shares during the period. Glenview Trust Co’s holdings in Lam Research were worth $43,443,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently added to or reduced their stakes in the business. Norges Bank purchased a new stake in shares of Lam Research in the fourth quarter worth about $3,645,427,000. Price T Rowe Associates Inc. MD raised its position in Lam Research by 352.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after acquiring an additional 10,666,540 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Lam Research in the second quarter valued at approximately $3,777,585,000. Franklin Resources Inc. lifted its holdings in Lam Research by 57.0% in the fourth quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock valued at $1,730,724,000 after acquiring an additional 3,671,073 shares during the period. Finally, Corient Private Wealth LLC boosted its position in Lam Research by 235.5% in the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock worth $890,040,000 after purchasing an additional 3,649,553 shares in the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Lam Research
In related news, Director Eric Brandt sold 54,500 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the transaction, the director directly owned 199,205 shares in the company, valued at approximately $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the transaction, the senior vice president owned 58,470 shares of the company’s stock, valued at approximately $18,102,312. This represents a 11.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 80,441 shares of company stock worth $27,614,296. Insiders own 0.31% of the company’s stock.
More Lam Research News
- Positive Sentiment: Lam Research raised its quarterly dividend by 27%, from $0.26 to $0.33 per share. The payment is scheduled for October 14, 2026, to shareholders of record on September 23. The increase signals confidence in cash generation and enhances shareholder returns, although future payments remain subject to board approval. Lam Research Corporation Announces a 27% Increase in Quarterly Dividend
- Positive Sentiment: The company broke ground on a 120,000-square-foot Oregon research laboratory as part of a more than $3 billion, five-year expansion of its global lab network. The investment is intended to accelerate equipment and process innovations for advanced AI chips and deepen collaboration with major customers, supporting Lam’s long-term AI-driven growth outlook. Lam Research Breaks Ground on New Oregon Lab
- Positive Sentiment: Recent operating momentum remains supportive: Lam’s latest reported quarter exceeded earnings and revenue expectations, with revenue up 30% year over year. Its exposure to AI-related chip manufacturing, recurring services revenue and strong balance sheet were also cited as reasons it may be preferable to some other chip stocks. Lam Research vs. Microchip
- Neutral Sentiment: Directors Michael R. Cannon and Sohail U. Ahmed are retiring from Lam Research’s board. The planned governance transition does not appear to change the company’s near-term business outlook, but investors may monitor board succession and strategic continuity. Lam Research Announces Director Retirements
- Neutral Sentiment: Chief Financial Officer Doug Bettinger is scheduled to participate in upcoming investor conferences, potentially providing additional commentary on semiconductor demand, AI spending and company guidance. Lam Research Announces Participation at Upcoming Conferences
- Negative Sentiment: Mizuho lowered its price target for Lam Research to $365, a potentially cautionary signal regarding valuation or near-term semiconductor-equipment conditions. The revised target remains above the price level described in the market background, limiting the severity of the negative read-through. Mizuho Lowers Lam Research Price Target
Lam Research Stock Performance
Shares of NASDAQ:LRCX opened at $318.58 on Friday. Lam Research Corporation has a 1 year low of $94.11 and a 1 year high of $438.50. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. The business’s 50 day moving average price is $332.17 and its 200-day moving average price is $289.05. The firm has a market capitalization of $398.65 billion, a PE ratio of 55.31, a P/E/G ratio of 1.24 and a beta of 1.84.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business’s revenue was up 30.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, equities research analysts expect that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.
Lam Research Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be issued a $0.33 dividend. This is a boost from Lam Research’s previous quarterly dividend of $0.26. This represents a $1.32 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Wednesday, September 23rd. Lam Research’s payout ratio is currently 18.06%.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on LRCX. Raymond James Financial set a $425.00 price objective on shares of Lam Research in a research note on Wednesday, June 10th. Citigroup reiterated a “buy” rating and issued a $450.00 target price (up from $315.00) on shares of Lam Research in a research note on Wednesday, June 17th. Rothschild & Co Redburn increased their price target on shares of Lam Research from $305.00 to $420.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Zacks Research upgraded shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 17th. Finally, Stifel Nicolaus lifted their price objective on shares of Lam Research from $325.00 to $425.00 and gave the company a “buy” rating in a report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $357.31.
Read Our Latest Stock Report on LRCX
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Recommended Stories
- Five stocks we like better than Lam Research
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
